Public Employees Retirement System of Ohio Takes $2.17 Million Position in Smith & Nephew SNATS, Inc. $SNN

Public Employees Retirement System of Ohio purchased a new position in Smith & Nephew SNATS, Inc. (NYSE:SNN) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 34,605 shares of the medical equipment provider’s stock, valued at approximately $2,170,000.

Other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Smith & Nephew SNATS in the second quarter valued at about $505,323,000. Bank of America Corp DE purchased a new stake in shares of Smith & Nephew SNATS during the 2nd quarter worth about $97,223,000. Bank of New York Mellon Corp purchased a new stake in shares of Smith & Nephew SNATS during the 2nd quarter worth about $89,325,000. Caisse de depot et placement du Quebec acquired a new stake in shares of Smith & Nephew SNATS during the 2nd quarter valued at about $64,186,000. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Smith & Nephew SNATS by 49.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,771,401 shares of the medical equipment provider’s stock valued at $50,255,000 after buying an additional 583,809 shares during the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew SNATS Stock Up 0.1%

Shares of SNN stock opened at $28.91 on Monday. The stock’s 50 day simple moving average is $30.11 and its 200 day simple moving average is $31.42. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.11. Smith & Nephew SNATS, Inc. has a twelve month low of $28.48 and a twelve month high of $38.79.

Smith & Nephew SNATS Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, November 6th. Shareholders of record on Friday, October 2nd will be issued a dividend of $0.312 per share. This represents a yield of 205.0%. The ex-dividend date is Friday, October 2nd.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. BTIG Research initiated coverage on Smith & Nephew SNATS in a report on Monday, August 31st. They issued a “neutral” rating on the stock. Canaccord Genuity Group reduced their target price on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research note on Monday, May 11th. Wall Street Zen downgraded shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research report on Saturday. Morgan Stanley lowered shares of Smith & Nephew SNATS from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, September 2nd. Finally, Barclays cut shares of Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Smith & Nephew SNATS has a consensus rating of “Reduce” and a consensus price target of $30.93.

Smith & Nephew SNATS Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.